Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Breast Cancer Research and Treatment|August 1, 2022
An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancerElgene Lim, Frances Boyle, Meena Okera, et al.
Clinical Breast Cancer|November 5, 2020
nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast CancerErika Hamilton, Javier Cortes, Ozgur Ozyilkan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast CancerSara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun, et al.
International Journal of Molecular Sciences|August 12, 2022
Pharmacological Probes to Validate Biomarkers for Analgesic Drug DevelopmentJohannes van Niel, Petra Bloms-Funke, Ombretta Caspani, et al.
Clinical Pharmacology and Therapeutics|June 23, 2020
Opportunities for Quantitative Translational Modeling in OncologyJames W T Yates, Helen Byrne, Sonya C Chapman, et al.
The Lancet. Oncology|May 1, 2020
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trialSara M Tolaney, Andrew M Wardley, Stefania Zambelli, et al.
Frontiers in Oncology|February 28, 2022
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b StudySara M Tolaney, Muralidhar Beeram, J Thaddeus Beck, et al.
Trials|June 18, 2021
IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)André Mouraux, Petra Bloms-Funke, Irmgard Boesl, et al.
Trials|September 5, 2022
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activityCaterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, et al.
Trials|February 20, 2022
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)Zahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Pageof 3